Abstract: The primary aim of this study was to compare quality of life (QoL) in patients with Dementia with Lewy Bodies (DLB) and patients with Alzheimer disease (AD). The secondary aim of this study was to investigate determinants of QoL in DLB. Thirty-four patients with DLB at the Neuropsychiatry clinic, University Hospital MAS, Malmo¨, Sweden, were included in a cross-sectional study. These patients were matched to 34 patients with AD. Two QoL instruments, the EQ-5D instrument and the Quality of Life-Alzheimer disease (QoL-AD) instrument, were applied in this study. Both instruments were administered to both patients and caregivers. Patients with DLB in this study have significantly lower QoL than patients with AD regardless of instrument or whether patient or caregiver-reported QoL was used. Furthermore, this study shows that important determinants of QoL in DLB include Neuropsychiatric Inventory score, independency in instrumental activities of daily living, whether the patient is living with the caregiver and the presence of apathy and delusions.
D
ementia is established as one of the major challenges of this century owing to the enormous burden these pathologies impose on patients, caregivers, and society. In subjects over 65 years of age, crude prevalence rates for dementia in Europe vary between 5.9% and 9.4% with an exponential increase with age. 1 In 2 European population-based studies, the prevalence of Dementia with Lewy Bodies (DLB) was estimated to 21.9% (Finland) and 30.5% (UK) of all dementia disorders. 2 DLB is today considered to be the second most common degenerative dementia disorder after Alzheimer disease (AD).
The core criteria of DLB are fluctuating cognition, visual hallucinations, and spontaneous features of Parkinsonism. Other typical symptoms of DLB are rapid eye movement sleep behavior disorder and severe neuroleptic sensitivity. 3, 4 Taking into account the difference in clinical manifestation of DLB and AD, it is expected that the diseases differ in consequence for the patient, caregiver, and society. This study focuses on quality of life (QoL) of patients with DLB. Despite of an increasing interest in QoL studies, QoL research in AD is still considered to be in its infancy. 5 QoL in DLB is previously unstudied. QoL is an elusive concept that has been defined and assessed in various ways. Health-related QoL is a somewhat narrower concept relating to the impact of physical and mental disorders and disability on the general well being of a person. One problem is that there is no gold standard when measuring QoL. In this study, we use 2 widely used instruments, one generic and one specifically developed to assess QoL in patients with AD.
AIM
The primary aim of this study was to compare QoL in patients with DLB and patients with AD. The secondary aim of this study was to investigate cognition, behavioral disorders, disability, age, comorbidity, institutionalization, and whether the patient is living together with a caregiver or alone as determinants of QoL in DLB.
MATERIALS AND METHODS

Study Design
A total of 34 patients with DLB attending regular visits at the memory clinic, University Hospital MAS, Malmo¨, Sweden, were prospectively interviewed according to the same protocol as 272 patients with AD who attended regular visits at 6 memory clinics in Sweden, Finland, and Norway, earlier described by Jonsson et al.
the 34 patients with DLB according to sex, age, and cognitive function.
The matching was conducted by calculating a distance score between each possible pair of AD-DLB patients with matching sex. The distance score was equal to by the weighted sum of the squared differences in age and Minimental State Examination (MMSE) scores (MMSE scores were given a 5-fold higher weight than age, to ensure groups were primarily matched with respect to MMSE scores). Patients were then matched by selecting the AD-DLB patient pairs with the lowest distance scores ( Table 1) .
The DLB diagnosis was confirmed using the revised DLB criteria 4 : (1) Progressive cognitive decline of sufficient magnitude to interfere with normal social or occupational function, (2) at least 2 core features or 1 core feature and 1 suggestive feature have to be present. Core features are: fluctuating cognition with pronounced variations in attention and alertness, recurrent visual hallucinations that are typically well formed and detailed, and spontaneous features of parkinsonism. Suggestive features are: rapid eye movement sleep behavior disorder, severe neuroleptic sensitivity, abnormally low uptake in basal ganglia on single photon emission computed tomography dopamine transporter scan, and abnormally low uptake on [123I]meta-iodobenzylguanidine (MIBG) myocardial scintigraphy. The patients with AD fulfilled the ICD-10 criteria for AD.
Data Collection Procedure
The examination of the patients with DLB was designed similar to the data collection procedure in the AD group. 6 The DLB and AD groups were examined in their homes or at a memory clinic together with their primary caregiver.
The primary caregiver to the patients with DLB was in 20 cases the spouse, in 11 cases the patient's child, and in 3 cases a sibling. Cognitive function was assessed using MMSE. 7 Behavioral disturbances were measured using the Neuropsychiatric Inventory (NPI). 8 Patients with DLB were in addition examined regarding dependency in activities of daily living (ADL) using the Disability Assessment for Dementia scale 9 which includes 40 items: 17 related to basic self-care and 23 to instrumental activities of daily living (I-ADL).
Comorbidity was assessed in the DLB group using the same 12 domains used in the AD material. Information regarding prevalence of Parkinson disease had been gathered in the AD material, but was not analyzed as comorbidity in this study as a Parkinson disease diagnosis is in conflict with a DLB diagnosis.
QoL Instruments
Two QoL instruments, the EQ-5D instrument 10 and the Quality of Life-Alzheimer disease (QoL-AD) instrument, 11 were applied in this study. Both instruments were administered to both patients and caregivers.
The EQ-5D is a generic QoL instrument in which the respondent is asked to rate their current health state on 5 dimensions (mobility, hygiene, usual activities, pain/ discomfort, and anxiety/depression), with 3 possible levels for each dimension. For each of the possible health states, a utility weight can be assigned through an algorithm that has been developed on the basis of a time trade-off study in the United Kingdom. 12 The utility weight is a number <1, where 0 equals death and 1 equals perfect health, indicating the attractiveness of the health state based on the preferences of the general population. In contrast to the 2 other QoL scales used in this study, it is possible to obtain negative values of QoL using this method. The EQ-5D also includes a visual analog scale (VAS), anchored at perfect health (100) and death (0). Thus 2 values representing QoL are acquired using this instrument. Kendall coefficient of concordance regarding EQ-5D measurments has been estimated to W = 0.984 (P<0.001).
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The QoL-AD is a QoL instrument specifically developed for use in patients with AD. Thirteen domains (physical health, energy, mood, living situation, memory, family, marriage, friends, self, ability to do chores, ability to do things for fun, money, and life as a whole) are rated on a 4-point scale, 1 being poor and 4 being excellent. The maximum score is 52 and the minimum 13. The Internal consistency reliability for QoL-AD ranges from 0.84 to 0.88 for patient and caregiver-reported QoL in cognitively impaired patients. 11, 13 Patient and caregiver-reported QoL were analyzed separately as this study focused on caregiver-reported QoL.
Statistical Analysis
For statistical analysis SPSS 12.0.1 was used. Spearman rank order correlation was used to assess correlations between QoL-AD and the 2 values representing QoL that was acquired using EQ-5D as these values were not normally distributed. The Mann-Whitney U test was employed to test for differences in QoL scores between groups. Two linear regression analyses were done on caregiver-reported EQ-5D utility with an exclusion criterion for the examined determinants of P<0.10. The first regression analysis included NPI score, independency in I-ADL, age, comorbidity, institutionalization and whether the patient is living with primary caregiver. The second regression analysis included all NPI items as separate variables.
RESULTS
Ninety-four percent of the DLB patients' caregivers and 97% of the AD patients' caregivers were able to complete both QoL instruments adequately. Corresponding figures for patient reports were 59% in the DLB group and 76% in the AD group.
Demographic data and assessed possible determinants of QoL in DLB and AD are presented in Table 1 . The patients with DLB scored significantly higher on the brief NPI and were significantly more apathetic than the patients with AD. The higher prevalence of hallucinations in the DLB group compared with the AD group was expected as this symptom is included in the DLB criteria.
Patient and proxy-rated health-related QoL in DLB and AD are presented in Table 2 and Figure 1 . Two patients with AD and 8 patients with DLB scored negative values on EQ-5D utility. The correlations between EQ-5D utility scores, EQ-5D VAS scale and QoL-AD for all patients (DLB and AD) are presented in Table 3 . Table 4 presents 2 regression models of NPI score, independency in I-ADL and whether the patient was living with the primary caregiver were found to be significant determinants of QoL in DLB in the first regression analysis. Apathy and delusions were found to be determinants of QoL in DLB in the second regression analysis (Table 4) .
DISCUSSION
This is to our knowledge the first study to describe quality of life in patients with Lewy Body Dementia. The DLB and AD patients were not selected from the same population. There are some compatibility limitations to this method, however, the same investigational protocol was used, thus the data produced were considered to be comparable.
The strong correlations that were found between 3 QoL measures (QoL-AD, EQ-5D utility, and VAS scores) are in line with previous findings in AD. 6, 14, 15 In this study, the EQ-5D questions, excluding the VAS scale, were easier to answer than the QoL-AD questions; only 5.9% patients in the AD group and 29.4% of the patients in the DLB group were unable to complete the EQ-5D, compared with 32.4% of the AD patients and 35% of the DLB patients who were unable to complete the QoL-AD scale. The patients with DLB were to a greater extent unable to answer questions regarding QoL adequately compared with the patients with AD, although the patients with DLB and AD were matched regarding cognitive function. It was not the aim of this study to investigate the reason for this difference, however one may speculate that the greater prevalence of apathy in the DLB group may play an important role. Another possible contributing factor is poorer conversational skills among patients with DLB as reported by Ferman et al. 16 This result implicates the limits of trying to assess the general level of ability in dementia using only measurements of cognitive function.
The focus of this study is on caregiver-reported QoL as patient-reported QoL has been shown not to correlate with cognition or progression of the disease in patients with dementia, 14, 17 even though most healthy subjects would probably strongly prefer a health state with intact cognitive function to a state with severe cognitive impairment. The caregivers may be in a better position to provide estimates that reflect how patients might have interpreted their QoL had they been cognitively intact. Caution must, however, be taken when interpreting caregiver-reported QoL, as it is not only affected by factors concerning state of the patients, but also by factors concerning the caregiver, such as caregiver burden and caregiver depression. 18, 19 As in several previous studies, we found that caregiver-reported QoL was considerably lower than patient-reported QoL for all measurements. 6, 11, 15, 18 Whether to use proxy-reported QoL in patients with dementia is a debated issue. However, in this study the DLB patients have significantly lower QoL than the AD patients regardless of whether patient or caregiverreported QoL was used. A possible reason for this difference is a higher prevalence of behavioral disorders in the DLB group compared with the AD group. Our clinical impression is that apathy is particularly stigmatizing and prevalent in patients with DLB. This impression is supported by apathy being significantly more prevalent in the DLB group compared with the AD group, and also that apathy was associated with lower QoL within the DLB group in the multiple regression analysis. Another possible explanation of the difference in QoL in these cognitively matched DLB and AD groups is that a decreased cognitive level signals farther progression of the disease in DLB than it does in AD.
In 6% of the patients with AD and 24% of the patients with DLB the caregiver-rated EQ-5D scores corresponded to below-zero utility values according to the UK scoring algorithm. This indicates that the general population sample used to obtain the scoring algorithm considered these health states to be worse than death. The finding that almost 1 in 4 patients with DLB are in health states considered equal to or worse than death is alarming. The corresponding figure for the AD group was 6%, markedly less compared with the DLB group.
We found that NPI score, dependency in I-ADL, and whether the patient was living with the caregiver were significant determinants of QoL in DLB. NPI score and whether the patient was living with the caregiver were also found to be determinants for QoL in the complete AD group (n = 272) whereas I-ADL was not assessed in the AD study. 6 ADL and I-ADL have, however, been shown to be determinants of QoL in dementia in other studies. 20, 21 Apathy and delusions were the only NPI items that were individually significant determinants of QoL in DLB. Earlier studies indicate that apathy may be a general determinant of QoL in dementia. 22 Delusions were not as prevalent in the DLB group as apathy, but may be a specific determinant of QoL in DLB. There are no earlier reports of delusions as a determinant of QoL in dementia.
Cognitive function was not a determinant of QoL in DLB in this study. Cognitive function as a determinant of QoL in DLB has not previously been studied. In other dementias, cognitive function correlates with QoL in some studies, 14, 23 but not in others.
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The results of this study and an earlier study of resource utilization in DLB versus in AD, 24 indicate that the consequences of DLB and AD differ greatly; a DLB diagnosis predicts an almost 3-fold increase in resource utilization and a significantly lower QoL compared with AD. These results underline the importance making a correct differential diagnosis of degenerative dementia, as the diagnosis is likely to influence the gravity and type of problems that will have to be addressed during the course of the disease.
The QoL in caregivers to patients with DLB was not studied here, but should be examined in future studies as it is affected in other dementia disorders. 25, 26 To examine whether the extensive impairment of QoL in DLB is reversible, interventional studies that include QoL as an outcome measures are needed.
In summary, the results of this study suggest important differences in quality of life between patients with DLB and AD, and that important determinants of quality of life in DLB include NPI score, independency in I-ADL, whether the patient is living with the caregiver and the presence of apathy and delusions.
The present study is limited by a small sample size. More research is needed to confirm the findings of this study and to further examine other possible determinants of QoL in DLB such as motor dysfunction and autonomic dysfunction.
